SCHEMBL4819752

SCHEMBL4819752

CCOc1cc(C(O)c2ccc(OC)c(OCc3ccccc3)c2)ccc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
KMT2A Q03164 3/20 0.51
F2 P00734 3/20 0.51
F10 P00742 3/20 0.51
PRSS1 P07477 3/20 0.51
F7 P08709 3/20 0.51
PRSS2 P07478 2/20 0.51
F3 P13726 2/20 0.51
PRSS3 P35030 2/20 0.51
LMNA P02545 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
MAPT P10636 1/20 0.50
PDE4A P27815 2/20 0.49
PDE4B Q07343 2/20 0.49
PDE4C Q08493 2/20 0.49
PDE4D Q08499 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2060104 0.94 SMPD1 (0.56) SMPD1HDAC1HDAC8HDAC6KMT2A
SCHEMBL10702236 0.89 PDE4A (0.53) KMT2ALMNANPSR1MAPTPDE4A
SCHEMBL14168120 0.89 NPC1 (0.57) KMT2AF2F10PRSS1F7
SCHEMBL4818551 0.87 PPARG (0.51) LMNAPDE4APDE4BPDE4CPDE4D
SCHEMBL8843624 0.86 SMPD1 (0.53) SMPD1HDAC1HDAC8HDAC6KMT2A
SCHEMBL9586284 0.86 SMPD1 (0.56) SMPD1HDAC1HDAC8HDAC6KMT2A
SCHEMBL22420299 0.85 MAPK1 (0.46) SMPD1HDAC1HDAC8HDAC6KMT2A
SCHEMBL3565827 0.85 SMPD1 (0.54) SMPD1HDAC1HDAC8HDAC6KMT2A
SCHEMBL14242938 0.84 NPC1 (0.52) KMT2AF2F10PRSS1F7
SCHEMBL22420252 0.83 LMNA (0.46) KMT2AF2F10PRSS1F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7470723-B2 Diphenylethylene compounds and uses thereof CELGENE CORPORATION (US) 2008-12-30 US disclosed
EP-1799634-A2 DIPHENYLETHYLENE COMPOUNDS AND USES THEREOF CELGENE CORPORATION (US) 2007-06-27 EP disclosed
WO-2006026747-A2 DIPHENYLETHYLENE COMPOUNDS AND USES THEREOF CELGENE CORPORATION (US) 2006-03-09 WO disclosed
US-20050107339-A1 Diphenylethylene compounds and uses thereof CELGENE CORPORATION 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107339-A1 Diphenylethylene compounds and uses thereof VHL, TNF, PTGES SMPD1 1112/4885HDAC1 2443/4885HDAC8 2342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.